Kassassir et al. (2023) found that inhibiting p38 phosphorylation reduced the proliferation and invasion of CRC cells. Huang et al. (2023) reported that inhibiting IFI6 reversed OXA resistance in CRC cells by promoting ROS-induced p38. Here, IFI6 is linked to colorectal carcinoma.